Paul B Manning

Insider Reports History

Location
Charlottesville, VA
Signature
/s/ Charles Schoch, as Attorney-In-Fact for Paul B. Manning
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul B Manning:

Company Role Class Num Shares Value Price $ Report Date Ownership
Liquidia Corp Director Common Stock 469,583 $20,018,323 $42.63 11 Feb 2026 Direct
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Common Stock 3,958,189 $16,792,616 $4.24 25 Nov 2025 Direct
Candel Therapeutics, Inc. Director Common Stock 2,763,527 $15,061,222 $5.45 23 Feb 2026 By Paul B. Manning Revocable Trust
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Common Stock 3,348,372 $14,205,468 $4.24 25 Nov 2025 Indirect
Candel Therapeutics, Inc. Director Common Stock 1,681,000 $10,254,100 $6.10 23 Feb 2026 Direct
Candel Therapeutics, Inc. Director Common Stock 1,303,752 $7,952,887 $6.10 23 Feb 2026 By BKB Growth Investments, LLC
Taysha Gene Therapies, Inc. 10%+ Owner Common Stock 2,841,704 $7,814,686 $2.75 30 May 2025 Indirect
Acumen Pharmaceuticals, Inc. 10%+ Owner Common Stock 657,985 $2,283,603 $3.47 06 Jul 2021 Indirect
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Common Stock 332,433 $1,173,488 $3.53 25 Nov 2025 By trust
Liquidia Corp Director Common Stock 0 $0 $42.63 11 Feb 2026 Indirect
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series A Warrants (right to buy) 9,213,483 22 Nov 2024 Direct
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series B Warrants (right to buy) 9,213,483 22 Nov 2024 Direct
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series A Warrants (right to buy) 2,247,191 22 Nov 2024 Indirect
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series B Warrants (right to buy) 2,247,191 22 Nov 2024 Indirect
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series C Warrant (right to buy) 687,690 25 Nov 2025 Indirect
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series C Warrant (right to buy) 343,845 25 Nov 2025 Direct
Candel Therapeutics, Inc. Director Stock Option (Right to Buy) 14,240 17 Jun 2025 Direct
Acumen Pharmaceuticals, Inc. 10%+ Owner Series A-1 Preferred Stock 0 06 Jul 2021 Indirect
Acumen Pharmaceuticals, Inc. 10%+ Owner Series B Preferred Stock 0 06 Jul 2021 Indirect

Insider Reports Filed by Paul B Manning

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CADL Candel Therapeutics, Inc. 23 Feb 2026 1 +$2,999,996 4 Director 26 Feb 2026, 19:38
LQDA Liquidia Corp 11 Feb 2026 2 $0 4 Director 12 Feb 2026, 21:16
VRCA Verrica Pharmaceuticals Inc. 25 Nov 2025 4 +$17,505,157 4 Director, 10%+ Owner 25 Nov 2025, 19:00
LQDA Liquidia Corp 28 Aug 2025 4 -$18,957,475 4 Director 02 Sep 2025, 19:46
CADL Candel Therapeutics, Inc. 25 Jun 2025 1 +$4,999,996 4 Director 26 Jun 2025, 08:30
LQDA Liquidia Corp 17 Jun 2025 1 $0 4 Director 20 Jun 2025, 16:32
CADL Candel Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 18 Jun 2025, 08:35
TSHA Taysha Gene Therapies, Inc. 30 May 2025 1 +$2,062,500 4 10%+ Owner 03 Jun 2025, 21:38
CADL Candel Therapeutics, Inc. 16 Dec 2024 2 +$7,500,000 4 Director 18 Dec 2024, 16:11
VRCA Verrica Pharmaceuticals Inc. 22 Nov 2024 7 $0 4 Director, 10%+ Owner 26 Nov 2024, 16:15
VRCA Verrica Pharmaceuticals Inc. 19 Sep 2024 4 $0 4 Director, 10%+ Owner 23 Sep 2024, 16:15
LQDA Liquidia Corp 12 Sep 2024 1 +$2,999,994 4 Director 16 Sep 2024, 16:05
TSHA Taysha Gene Therapies, Inc. 27 Jun 2024 1 +$2,999,999 4 10%+ Owner 01 Jul 2024, 08:00
CADL Candel Therapeutics, Inc. 26 Jun 2024 1 $0 4 Director 27 Jun 2024, 08:37
LQDA Liquidia Corp 20 Jun 2024 1 $0 4 Director 24 Jun 2024, 21:39
LQDA Liquidia Corp 14 Dec 2023 1 +$2,000,003 4 Director 18 Dec 2023, 17:00
TSHA Taysha Gene Therapies, Inc. 17 Nov 2023 1 +$163,000 4 10%+ Owner 20 Nov 2023, 07:35
TSHA Taysha Gene Therapies, Inc. 16 Aug 2023 1 +$14,820,000 4 10%+ Owner 16 Aug 2023, 20:57
VRCA Verrica Pharmaceuticals Inc. 24 Jul 2023 1 +$1,004,000 4 Director, 10%+ Owner 24 Jul 2023, 18:47
CADL Candel Therapeutics, Inc. 28 Jun 2023 1 $0 4 Director 29 Jun 2023, 09:00
LQDA Liquidia Corp 19 Jun 2023 1 $0 4 Director 21 Jun 2023, 17:01
TSHA Taysha Gene Therapies, Inc. 31 Oct 2022 1 +$3,000,000 4 Director, 10%+ Owner 02 Nov 2022, 16:09
CADL Candel Therapeutics, Inc. 13 Oct 2022 1 $0 4 Director 17 Oct 2022, 16:36
VRCA Verrica Pharmaceuticals Inc. 05 Jul 2022 1 +$9,999,998 4 Director, 10%+ Owner 05 Jul 2022, 16:10
TSHA Taysha Gene Therapies, Inc. 17 Jun 2022 1 $0 4 Director, 10%+ Owner 22 Jun 2022, 16:36
LQDA Liquidia Corp 17 Jun 2022 1 $0 4 Director 22 Jun 2022, 16:31
LQDA Liquidia Corp 18 Apr 2022 1 +$1,999,996 4 Director 19 Apr 2022, 16:30
LQDA Liquidia Corp 31 Mar 2022 1 $0 4 Director 20 Apr 2022, 16:36
TSHA Taysha Gene Therapies, Inc. 02 Feb 2022 5 +$1,571,810 4 Director, 10%+ Owner 04 Feb 2022, 07:28
LQDA Liquidia Corp 31 Dec 2021 0 $0 5/A Director, 10%+ Owner 04 May 2022, 16:51
VRCA Verrica Pharmaceuticals Inc. 31 Dec 2021 2 $0 5 Director, 10%+ Owner 14 Feb 2022, 20:15
CADL Candel Therapeutics, Inc. 31 Dec 2021 1 $0 5 Director, 10%+ Owner 14 Feb 2022, 15:37
VRCA Verrica Pharmaceuticals Inc. 02 Dec 2021 2 +$467,905 4 Director, 10%+ Owner 06 Dec 2021, 07:20
TSHA Taysha Gene Therapies, Inc. 24 Nov 2021 1 +$29,044 4 Director, 10%+ Owner 29 Nov 2021, 16:01
TSHA Taysha Gene Therapies, Inc. 23 Nov 2021 1 +$250,800 4 Director, 10%+ Owner 24 Nov 2021, 06:58
LQDA Liquidia Corp 20 Aug 2021 1 $0 4 Director 01 Sep 2021, 17:24
CADL Candel Therapeutics, Inc. 29 Jul 2021 5 +$13,000,000 4/A Director, 10%+ Owner 04 Aug 2021, 16:41
CADL Candel Therapeutics, Inc. 27 Jul 2021 2 +$410,778 4 Director 29 Jul 2021, 21:02
CADL Candel Therapeutics, Inc. 26 Jul 2021 0 $0 3 Director 26 Jul 2021, 21:24
ABOS Acumen Pharmaceuticals, Inc. 06 Jul 2021 6 +$5,000,000 4 10%+ Owner 08 Jul 2021, 18:35
ABOS Acumen Pharmaceuticals, Inc. 30 Jun 2021 0 $0 3 10%+ Owner 30 Jun 2021, 19:11
TSHA Taysha Gene Therapies, Inc. 17 Jun 2021 1 $0 4 Director, 10%+ Owner 21 Jun 2021, 16:59
TSHA Taysha Gene Therapies, Inc. 14 May 2021 1 +$251,760 4 Director, 10%+ Owner 17 May 2021, 07:48